Replies to post #20710 on Biotech Values

[drbio45]

Do you mean the lack of interaction with warfarin (which was reported in MYOG’s PR)? This has also been cited by Actelion as an advantage of Tracleer vis-à-vis ENCY’s Thelin.

I meant warfarin, easy to mix the two up.